Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
Global HIV Study Finds That Cardiovascular ... Targeted Immune Intervention and Stopping ART in Model of SIV Infection Leads to Control of Viral Replication and Reservoirs Sep. 12, 2024 ...
SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...